Skip to content
Acredit

Acredit

  • The Acredit Network
  • About ACREDIT
    • About ACREDIT
    • CMOR
    • Translational Cancer Therapy
    • Ahus Gastrointestinal Radiology (Gastrorad) Research Group
    • Image guided surgery and minimal intervention
    • Clinical and translational cancer research
    • Vacancies
  • About Colorectal Cancer
  • News
  • Research
    • METIMMOX
    • The LARC-RRP study
    • LARC-EX study
    • The OSLO-CoMet study
    • The ImmunoPeCa study
    • The OxyTarget study
    • The MetAction study
    • The EuroPMP COST Action
    • Cure4PMP
    • The PRAVO study
    • The Bone Marrow Micrometastasis in Colorectal Cancer study
  • Privacy Policy
  • Contact Information
Acredit

oxaliplatin

Research 

New Paper Looks into Patient-Derived Xenograft Models

25/05/202027/05/2020 acredit cabazitaxel, capecitabine, irinotecan, oxaliplatin, Peritoneal Metastasis, regorafenib, Xenograft

Acredit’s Karianne Giller Fleten has published a paper entitled “Experimental treatment of mucinous peritoneal metastases using patient-derived xenograft models”.  In

Read more
Research 

ICD via Oxaliplatin and Radiation

18/12/201922/07/2020 acredit ICD, oxaliplatin, radiation

ACREDIT’s own Dr Simer Jit Bains has published a new paper looking into immune response in patients undergoing neoadjuvant oxaliplatin

Read more
Research 

Conversion of CLM using HAI

17/12/201922/07/2020 acredit CLM, FLT3LG, HAI, metastasis, oxaliplatin

A new paper has been published by ACREDIT’s Dr Hanna Abrahamsson looking into the conversion of primarily unresectable liver metastases

Read more
Copyright © 2022 Acredit. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.